At the onset, pancreatic cells compensated for increased glucose levels by doubling insulin secretion (detectable within 2 weeks), but insulin secretion became significantly impaired as insulin resistance developed and β-cell mass continued to increase [47]. The gene discussed is INS; the disease is Insulin resistance.